Spero Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Spero Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q2 2024.
  • Spero Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $3.64M, a 21.6% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $3.64M -$1M -21.6% Jun 30, 2024 10-Q 2024-08-05
Q1 2024 $3.9M -$986K -20.2% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $4.16M -$969K -18.9% Dec 31, 2023 10-Q 2024-08-05
Q3 2023 $4.4M -$952K -17.8% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $4.65M -$936K -16.8% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $4.89M -$1.42M -22.5% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $5.12M -$1.41M -21.5% Dec 31, 2022 10-K 2024-03-13
Q3 2022 $5.36M -$1.14M -17.5% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $5.58M -$1.12M -16.7% Jun 30, 2022 10-Q 2022-08-10
Q1 2022 $6.31M -$606K -8.76% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $6.53M -$584K -8.21% Dec 31, 2021 10-K 2023-03-30
Q3 2021 $6.5M -$817K -11.2% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $6.71M +$1.85M +38.1% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $6.92M +$2.15M +45.1% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $7.11M +$2.24M +45.9% Dec 31, 2020 10-K 2022-03-31
Q3 2020 $7.31M +$3.37M +85.4% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $4.85M +$667K +15.9% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $4.77M +$396K +9.06% Mar 31, 2020 10-Q 2020-05-08
Q4 2019 $4.88M Dec 31, 2019 10-K 2021-03-11
Q3 2019 $3.94M Sep 30, 2019 10-Q 2019-11-04
Q2 2019 $4.19M Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $4.37M Mar 31, 2019 10-Q 2019-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.